Scott T. Chiesa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Scott T. Chiesa has a total of 305 co-authors. Here are the top co-authors by number of shared publications:
- John Eric Deanfield
Institute of Cardiovascular Science, University College London, London, UK
12 shared publications - Alun David Hughes
Institute of Cardiovascular Science, University College London, London, UK
11 shared publications Marietta Charakida
Department of Imaging Science and Biomedical Engineering King’s College London UK
11 shared publications- Steven J. Trangmar
University of Roehampton
9 shared publications John E. Deanfield
Institute of Cardiovascular Science University College London UK
8 shared publicationsGeorgios Georgiopoulos
Department of Imaging Science and Biomedical Engineering King’s College London UK
7 shared publications
Latest Publications
- Open Access
- 5 May 2026
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 8 (3)
Early-life blood pressure and midlife brain and cognitive health: tests in two birth cohorts
Elevated blood pressure (BP) in midlife is a well-established risk factor for impaired brain health and cognitive ability in old age. We hypothesized that exposure to elevated BP within the first five decades of life may contribute to this risk through impacts on brain health and/or cognitive ability evident by midlife. Participants (n = 893) were selected from the Dunedin Multidisciplinary Health and Development Study (The Dunedin Study). Exposures were systolic (SBP) and diastolic (DBP) blood pressures measured at ages 7, 11, 18, 26, 32, 38 and 45. Cumulative early-life exposure to blood pressure was also quantified as the area under the curve (AUC). Brain health was assessed at age 45 via imaging measures comprising BrainAGE (difference between chronological age and age predicted from machine-learning models of brain-imaging data), white matter hyperintensity (WMH) burden, and retinal arteriolar calibres (RAC)—a proxy for cerebral small vessel remodelling. Cognitive ability (assessed using IQ) was also measured at age 45, with replication of cognitive findings tested in a larger contemporary cohort, the 1970 British Cohort Study. We found limited evidence for any association between BP in the first four decades of life and brain health or cognitive ability at age 45. Most associations instead emerged for BP from early-midlife onwards. Midlife BP was associated with older BrainAGE (Beta for DBP at age 45 = 0.11 [0.04, 0.19]; P = 0.003) and higher WMH burden (Beta = 0.09 [0.02, 0.17]; P = 0.019). Effect estimates for SBP were similar. For cognitive ability, DBP at ages 38 and 45 showed modest associations with age 45 IQ, which became null after accounting for childhood IQ. These findings were broadly replicated in the 1970 British Cohort Study for age 47 IQ. Only RAC in The Dunedin Study were found to associate with BP from childhood (Beta for age 7 DBP = −0.09 [−0.16, −0.03]; P = 0.006), and the magnitude of these estimates increased during midlife (Beta at age 45 = −0.37 [−0.45, −0.30]; P < 0.001). We found little evidence for any association between BP prior to age 40 and BrainAGE, WMH volume, or cognitive ability in midlife. However, cumulative exposure to elevated BP from childhood was associated with reduced RAC, suggesting a potential link between BP and adverse cerebral small vessel remodelling from childhood.
- 5 May 2026
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 8 (3)
Open AccessEarly-life blood pressure and midlife brain and cognitive health: tests in two birth cohorts
Elevated blood pressure (BP) in midlife is a well-established risk factor for impaired brain health and cognitive ability in old age. We hypothesized that exposure to elevated BP within the first five decades of life may contribute to this risk through impacts on brain health and/or cognitive ability evident by midlife. Participants (n = 893) were selected from the Dunedin Multidisciplinary Health and Development Study (The Dunedin Study). Exposures were systolic (SBP) and diastolic (DBP) blood pressures measured at ages 7, 11, 18, 26, 32, 38 and 45. Cumulative early-life exposure to blood pressure was also quantified as the area under the curve (AUC). Brain health was assessed at age 45 via imaging measures comprising BrainAGE (difference between chronological age and age predicted from machine-learning models of brain-imaging data), white matter hyperintensity (WMH) burden, and retinal arteriolar calibres (RAC)—a proxy for cerebral small vessel remodelling. Cognitive ability (assessed using IQ) was also measured at age 45, with replication of cognitive findings tested in a larger contemporary cohort, the 1970 British Cohort Study. We found limited evidence for any association between BP in the first four decades of life and brain health or cognitive ability at age 45. Most associations instead emerged for BP from early-midlife onwards. Midlife BP was associated with older BrainAGE (Beta for DBP at age 45 = 0.11 [0.04, 0.19]; P = 0.003) and higher WMH burden (Beta = 0.09 [0.02, 0.17]; P = 0.019). Effect estimates for SBP were similar. For cognitive ability, DBP at ages 38 and 45 showed modest associations with age 45 IQ, which became null after accounting for childhood IQ. These findings were broadly replicated in the 1970 British Cohort Study for age 47 IQ. Only RAC in The Dunedin Study were found to associate with BP from childhood (Beta for age 7 DBP = −0.09 [−0.16, −0.03]; P = 0.006), and the magnitude of these estimates increased during midlife (Beta at age 45 = −0.37 [−0.45, −0.30]; P < 0.001). We found little evidence for any association between BP prior to age 40 and BrainAGE, WMH volume, or cognitive ability in midlife. However, cumulative exposure to elevated BP from childhood was associated with reduced RAC, suggesting a potential link between BP and adverse cerebral small vessel remodelling from childhood.
- 13 January 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (2) , e6-e7
Response by Sittichokkananon et al to Letter Regarding Article, “Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes”
- 13 January 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (2) , e6-e7
Response by Sittichokkananon et al to Letter Regarding Article, “Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes”
- Open Access
- 23 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S6) , e101505
Cardiovascular risk factors and cognitive ability across eight decades of life: a cross‐sectional analysis of the Understanding Society UK Household Longitudinal Study
Background: Cardiovascular risk factor exposures in midlife have repeatedly been linked to cognitive impairment and dementia. How early in the lifespan these associations emerge, however, and whether they remain stable over time, remains poorly studied. This study aimed to characterize lifespan associations between cardiovascular risk factors and cognitive ability in a cross‐sectional study of up to 34,684 participants aged 20–100 years participating in Understanding Society: The UK Household Longitudinal Study. Method: Multivariable regression analyses with interaction terms were tested across each decade of age to cross‐sectionally characterise associations between optimal and suboptimal levels of eight risk factors (BMI, HbA1c, SBP and DBP, non‐HDL and HDL cholesterol, smoking status, and sleep duration) and a latent measure of cognitive ability underlying five cognitive domains (immediate/delayed verbal declarative memory, working memory/concentration, semantic fluency, and reasoning). All analyses were adjusted for sex and highest attained education level. Inverse‐probability weighting was used to ensure results were representative of the UK population. Result: Mean cognitive ability was stable in the cohort in young adulthood, showed moderate decline across midlife, and accelerated decline from age 70 onwards. Higher levels of HbA1c, lower levels of HDLc, smoking, and poor sleep were found to consistently associate with lower levels of cognitive ability across virtually the entire lifespan (main effect p <0.001 for all risk factors). Higher BMI – but not blood pressure – was found to associate with lower cognitive ability during midlife alone. The majority of these associations were either lost or reversed in the oldest old, albeit with less precise estimates at this age due to lower participant numbers. Conclusion: Commonly observed associations linking midlife cardiovascular risk factors to cognitive impairment may in part represent established differences persisting from the earliest decades of life. Future work investigating the causality and directionality of these relationships is warranted.
- 23 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S6) , e101505
Open AccessCardiovascular risk factors and cognitive ability across eight decades of life: a cross‐sectional analysis of the Understanding Society UK Household Longitudinal Study
Background: Cardiovascular risk factor exposures in midlife have repeatedly been linked to cognitive impairment and dementia. How early in the lifespan these associations emerge, however, and whether they remain stable over time, remains poorly studied. This study aimed to characterize lifespan associations between cardiovascular risk factors and cognitive ability in a cross‐sectional study of up to 34,684 participants aged 20–100 years participating in Understanding Society: The UK Household Longitudinal Study. Method: Multivariable regression analyses with interaction terms were tested across each decade of age to cross‐sectionally characterise associations between optimal and suboptimal levels of eight risk factors (BMI, HbA1c, SBP and DBP, non‐HDL and HDL cholesterol, smoking status, and sleep duration) and a latent measure of cognitive ability underlying five cognitive domains (immediate/delayed verbal declarative memory, working memory/concentration, semantic fluency, and reasoning). All analyses were adjusted for sex and highest attained education level. Inverse‐probability weighting was used to ensure results were representative of the UK population. Result: Mean cognitive ability was stable in the cohort in young adulthood, showed moderate decline across midlife, and accelerated decline from age 70 onwards. Higher levels of HbA1c, lower levels of HDLc, smoking, and poor sleep were found to consistently associate with lower levels of cognitive ability across virtually the entire lifespan (main effect p <0.001 for all risk factors). Higher BMI – but not blood pressure – was found to associate with lower cognitive ability during midlife alone. The majority of these associations were either lost or reversed in the oldest old, albeit with less precise estimates at this age due to lower participant numbers. Conclusion: Commonly observed associations linking midlife cardiovascular risk factors to cognitive impairment may in part represent established differences persisting from the earliest decades of life. Future work investigating the causality and directionality of these relationships is warranted.
- Open Access
- 23 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S6) , e098001
Childhood brain size mediates the relationship between birthweight and early‐life cognitive ability
Background: Low cognitive ability in the early decades of life is associated with an increased risk of dementia in old age. Weight and head size are closely correlated developmental markers routinely measured at birth and during infancy and have both been shown to associate with cognitive development in early childhood. We aimed to 1) test whether these associations remained during the transition to adolescence and 2) identify potential mediating pathways linking these factors in the interim years. Method: Data from 4,896 participants born at a gestational age ≥ 37 weeks and with birthweight ≥ 2.5kg were assessed within the Avon Longitudinal Study of Parents and Children (ALSPAC). Weight and head circumference (as a proxy for brain size) were measured at birth, 8, and 15 years. IQ (as a proxy for early cognitive reserve) was derived at 4, 8, and 15 years. Linear regression and structural equation models (SEM) were used assess interrelationships between weight, head circumference and cognitive function across childhood and adolescence while controlling for gestational age, sex, parent's education, and household social class. Result: Regression analyses demonstrated evidence for independent associations between both weight and head circumference at birth with IQ at ages 4, 8, and 15. Effect sizes between birthweight and IQ weakened with the passing of time (SD‐difference [95%CI]=0.14[0.01,0.27] at age 4 to 0.04[0.00,0.09] at age 15), but remained consistent for birth head circumference (∼0.10 throughout). SEM identified multiple indirect pathways linking head circumference at birth to IQ in adolescence, all operating via early differences in childhood IQ and head size by the age of 8 years. In contrast, no pathways linking birthweight to any measure of IQ were identified after accounting for accompanying covariance with head size. Conclusion: Early differences in brain size and IQ established during the formative years of life likely explain much of the association linking early‐life weight status to later cognitive ability and reserve.
- 23 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S6) , e098001
Open AccessChildhood brain size mediates the relationship between birthweight and early‐life cognitive ability
Background: Low cognitive ability in the early decades of life is associated with an increased risk of dementia in old age. Weight and head size are closely correlated developmental markers routinely measured at birth and during infancy and have both been shown to associate with cognitive development in early childhood. We aimed to 1) test whether these associations remained during the transition to adolescence and 2) identify potential mediating pathways linking these factors in the interim years. Method: Data from 4,896 participants born at a gestational age ≥ 37 weeks and with birthweight ≥ 2.5kg were assessed within the Avon Longitudinal Study of Parents and Children (ALSPAC). Weight and head circumference (as a proxy for brain size) were measured at birth, 8, and 15 years. IQ (as a proxy for early cognitive reserve) was derived at 4, 8, and 15 years. Linear regression and structural equation models (SEM) were used assess interrelationships between weight, head circumference and cognitive function across childhood and adolescence while controlling for gestational age, sex, parent's education, and household social class. Result: Regression analyses demonstrated evidence for independent associations between both weight and head circumference at birth with IQ at ages 4, 8, and 15. Effect sizes between birthweight and IQ weakened with the passing of time (SD‐difference [95%CI]=0.14[0.01,0.27] at age 4 to 0.04[0.00,0.09] at age 15), but remained consistent for birth head circumference (∼0.10 throughout). SEM identified multiple indirect pathways linking head circumference at birth to IQ in adolescence, all operating via early differences in childhood IQ and head size by the age of 8 years. In contrast, no pathways linking birthweight to any measure of IQ were identified after accounting for accompanying covariance with head size. Conclusion: Early differences in brain size and IQ established during the formative years of life likely explain much of the association linking early‐life weight status to later cognitive ability and reserve.
- 20 October 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (11) , e167-e168
Comment on Agbaje et al. Persistent Hyperglycemia and Insulin Resistance With the Risk of Worsening Cardiac Damage in Adolescents: A 7-Year Longitudinal Study of the ALSPAC Birth Cohort. Diabetes Care 2025;48:896–904
- 20 October 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (11) , e167-e168
Comment on Agbaje et al. Persistent Hyperglycemia and Insulin Resistance With the Risk of Worsening Cardiac Damage in Adolescents: A 7-Year Longitudinal Study of the ALSPAC Birth Cohort. Diabetes Care 2025;48:896–904
- Open Access
- 19 August 2025
- Published by Oxford University Press (OUP) in European Heart Journal
Periodontitis treatment and progression of carotid intima-media thickness: a randomized trial
Background and Aims: Intensive periodontal treatment (IPT) improves endothelial function in patients with periodontitis (PD). However, whether these changes can slow the progression of structural vascular remodelling remains unclear. This randomized clinical trial evaluated the impact of IPT on carotid intima-media thickness (cIMT) over 2 years (NCT03072342). Flow-mediated dilatation (FMD), blood pressure and pulse wave velocity (PWV) were assessed as secondary outcomes, while markers of inflammation, oxidative stress, and metabolomics were explanatory outcomes. Methods: 135 consecutive, otherwise healthy participants with PD, were enrolled in a single-blind, single-centre, controlled trial, and randomized to IPT (n = 68; including scaling, root planning, and, when appropriate, surgical corrective therapy) or control periodontal treatment (CPT, n = 67; including supra-gingival scaling and polishing). cIMT was assessed at baseline, 12 and 24 months post-therapy. Blood pressure, FMD, PWV, markers of inflammation, oxidative stress, and metabolomics were assessed at baseline and at 2, 6, 12, 18, and 24 months post-intervention. Results: After 24 months, cIMT was lower in the IPT vs the CPT group (−0.023 mm, 95% confidence interval −0.030.019 to −0.0227, P < 0.0001). FMD improved within 2 months in the IPT group and remained consistently higher than the CPT group throughout the study (P < 0.0001) correlating with the improved periodontal measurements at the same time points. No substantial differences were observed between groups in adverse events, anthropometric, blood pressure, PWV, or metabolomic markers. Among inflammatory and oxidative stress markers, glycoprotein acetyl was reduced in IPT compared with the CPT group participants (P < 0.05). Conclusions: IPT led to favourable structural changes in the vascular phenotype, underscoring the impact of PD on cardiovascular health and further highlighting the potential role of treating PD to improve cardiovascular outcomes.
- 19 August 2025
- Published by Oxford University Press (OUP) in European Heart Journal
Open AccessPeriodontitis treatment and progression of carotid intima-media thickness: a randomized trial
Background and Aims: Intensive periodontal treatment (IPT) improves endothelial function in patients with periodontitis (PD). However, whether these changes can slow the progression of structural vascular remodelling remains unclear. This randomized clinical trial evaluated the impact of IPT on carotid intima-media thickness (cIMT) over 2 years (NCT03072342). Flow-mediated dilatation (FMD), blood pressure and pulse wave velocity (PWV) were assessed as secondary outcomes, while markers of inflammation, oxidative stress, and metabolomics were explanatory outcomes. Methods: 135 consecutive, otherwise healthy participants with PD, were enrolled in a single-blind, single-centre, controlled trial, and randomized to IPT (n = 68; including scaling, root planning, and, when appropriate, surgical corrective therapy) or control periodontal treatment (CPT, n = 67; including supra-gingival scaling and polishing). cIMT was assessed at baseline, 12 and 24 months post-therapy. Blood pressure, FMD, PWV, markers of inflammation, oxidative stress, and metabolomics were assessed at baseline and at 2, 6, 12, 18, and 24 months post-intervention. Results: After 24 months, cIMT was lower in the IPT vs the CPT group (−0.023 mm, 95% confidence interval −0.030.019 to −0.0227, P < 0.0001). FMD improved within 2 months in the IPT group and remained consistently higher than the CPT group throughout the study (P < 0.0001) correlating with the improved periodontal measurements at the same time points. No substantial differences were observed between groups in adverse events, anthropometric, blood pressure, PWV, or metabolomic markers. Among inflammatory and oxidative stress markers, glycoprotein acetyl was reduced in IPT compared with the CPT group participants (P < 0.05). Conclusions: IPT led to favourable structural changes in the vascular phenotype, underscoring the impact of PD on cardiovascular health and further highlighting the potential role of treating PD to improve cardiovascular outcomes.
- Open Access
- 29 April 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (17) , 1235-1247
Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes
BACKGROUND: Shared genetic and lifestyle risk factors may underlie the development of both coronary artery disease (CAD) and dementia. We examined whether an increased genetic risk for CAD is associated with long-term risk of developing all-cause, Alzheimer’s, or vascular dementia, and investigated whether differences in potentially modifiable lifestyle factors in the mid- to late-life period may attenuate this risk. METHODS: A prospective cohort study of 365 782 participants free from dementia for at least 5 years after baseline assessment was conducted within the UK Biobank cohort. Genetic risk was assessed using a genomewide polygenic risk score (PRS) for CAD and lifestyle risk using a modified version of the American Heart Association’s Life’s Essential 8 Lifestyle Risk Score (LRS). Higher values for both scores were deemed to represent increased risk. Primary outcomes were incident all-cause, Alzheimer’s, and vascular dementia diagnoses obtained from self-report and electronic health records. Secondary outcomes were neuroimaging phenotypes measured in 32 028 participants recalled for magnetic resonance imaging. Sensitivity analyses were conducted to test the extent by which biological and behavioral risk factors contributed to observed associations. RESULTS: A total of 8870 cases of all-cause dementia were observed over a median 13.9-year follow-up. Both genetic (PRS) and lifestyle (LRS) risk scores for CAD were associated with a modestly elevated risk of all-cause dementia (subhazard ratio per SD increase, 1.10 [1.08, 1.12], P P =0.006, for LRS). This risk appeared largely attributable to underlying vascular dementia diagnoses (subhazard ratio, 1.16 [1.11, 1.21], P P P P P <0.001 for all). In a subset of individuals recalled for neuroimaging assessments, those in the highest tertiles for genetic and lifestyle risk for CAD demonstrated a ≈25% greater volume of white matter hyperintensities than those in the lowest risk tertiles, but showed little difference in gray matter or hippocampal volumes. Sensitivity analyses identified associations between both biological and behavioral risk scores with white matter hyperintensity burden and vascular dementia, whereas some Alzheimer’s dementia associations showed seemingly paradoxical relationships. CONCLUSIONS: Individuals who are genetically predisposed to developing CAD also face an increased risk of developing dementia in old age. This risk is reduced in those demonstrating healthy lifestyle profiles earlier in the lifespan, particularly in those who may be at an increased risk of developing dementia caused by an underlying vascular pathology.
- 29 April 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (17) , 1235-1247
Open AccessGenetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes
BACKGROUND: Shared genetic and lifestyle risk factors may underlie the development of both coronary artery disease (CAD) and dementia. We examined whether an increased genetic risk for CAD is associated with long-term risk of developing all-cause, Alzheimer’s, or vascular dementia, and investigated whether differences in potentially modifiable lifestyle factors in the mid- to late-life period may attenuate this risk. METHODS: A prospective cohort study of 365 782 participants free from dementia for at least 5 years after baseline assessment was conducted within the UK Biobank cohort. Genetic risk was assessed using a genomewide polygenic risk score (PRS) for CAD and lifestyle risk using a modified version of the American Heart Association’s Life’s Essential 8 Lifestyle Risk Score (LRS). Higher values for both scores were deemed to represent increased risk. Primary outcomes were incident all-cause, Alzheimer’s, and vascular dementia diagnoses obtained from self-report and electronic health records. Secondary outcomes were neuroimaging phenotypes measured in 32 028 participants recalled for magnetic resonance imaging. Sensitivity analyses were conducted to test the extent by which biological and behavioral risk factors contributed to observed associations. RESULTS: A total of 8870 cases of all-cause dementia were observed over a median 13.9-year follow-up. Both genetic (PRS) and lifestyle (LRS) risk scores for CAD were associated with a modestly elevated risk of all-cause dementia (subhazard ratio per SD increase, 1.10 [1.08, 1.12], P P =0.006, for LRS). This risk appeared largely attributable to underlying vascular dementia diagnoses (subhazard ratio, 1.16 [1.11, 1.21], P P P P P <0.001 for all). In a subset of individuals recalled for neuroimaging assessments, those in the highest tertiles for genetic and lifestyle risk for CAD demonstrated a ≈25% greater volume of white matter hyperintensities than those in the lowest risk tertiles, but showed little difference in gray matter or hippocampal volumes. Sensitivity analyses identified associations between both biological and behavioral risk scores with white matter hyperintensity burden and vascular dementia, whereas some Alzheimer’s dementia associations showed seemingly paradoxical relationships. CONCLUSIONS: Individuals who are genetically predisposed to developing CAD also face an increased risk of developing dementia in old age. This risk is reduced in those demonstrating healthy lifestyle profiles earlier in the lifespan, particularly in those who may be at an increased risk of developing dementia caused by an underlying vascular pathology.
- Open Access
- 20 December 2024
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 5 (12) , 100665
Next generation brain health: transforming global research and public health to promote prevention of dementia and reduce its risk in young adult populations
- 20 December 2024
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 5 (12) , 100665
Open AccessNext generation brain health: transforming global research and public health to promote prevention of dementia and reduce its risk in young adult populations
- Open Access
- 3 December 2024
- Published by Elsevier in EBioMedicine
- Vol. 110, 105490
Association of early life cardiovascular risk factors with grey matter structure in young adults in the United Kingdom: the ALSPAC study
- 3 December 2024
- Published by Elsevier in EBioMedicine
- Vol. 110, 105490
Open AccessAssociation of early life cardiovascular risk factors with grey matter structure in young adults in the United Kingdom: the ALSPAC study
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S7)
Cardiovascular Health and Cognitive Function in Early Midlife: A Cross‐Sectional Analysis of the 1970 British Cohort Study
Background: Poor cardiovascular health in midlife increases risk of dementia in later years. At least some of this risk may stem from early decrements in cognitive ability in those with poor cardiovascular health that are already evident by midlife. Whether such associations are causal, however, or develop in tandem due to shared factors encountered earlier in life, remains unclear.Method: A modified version of the American Heart Association Life’s Essential 8 (LE8) cardiovascular health score was constructed in 8,226 participants (age 47 years) recruited to the 1970 British Cohort Study. Four biological (BMI, blood pressure, glucose, total cholesterol) and four behavioral (diet, physical activity, smoking, sleep) metrics were each categorized as 0 (poor), 1 (intermediate), or 2 (ideal) and summed to create the LE8 score. A cognitive test battery assessing immediate and delayed memory recall, executive function, processing speed, and overall cognitive function were chosen as outcomes. Multiple linear regressions employing multiple imputation and adjusting for a range of early (childhood socioeconomic status, household overcrowding, childhood IQ, and highest education level) and mid‐life (current socioeconomic status and malaise) factors were used to conduct analyses whilst accounting for missing data.Result: Overall cognitive function in those classed as having ideal (LE8>13 points) cardiovascular health was 0.15 (0.04–0.27) z‐scores higher than those with intermediate (LE8 9‐13 points) and 0.42 (0.30–0.55) z‐scores higher than those with poor (<9 points) cardiovascular health. In age‐ and sex‐adjusted analyses, each 1‐point increase in LE8 was associated with a 0.02–0.06 z‐score higher cognitive function in all domains (p<0.001 for all). These associations became null for executive function and processing speed once accounting for early‐life factors, however, and were substantially attenuated for both memory domains. Further adjustment for midlife factors had little further impact on estimates. Follow‐up analyses suggested stronger relationships between midlife cardiovascular health behaviors and cognitive ability than biological factors.Conclusion: Much of the observed relationship between cardiovascular health and cognitive ability in early midlife is likely explained by other shared early‐life factors. While a modest association still persists after accounting for these factors, the directionality of this relationship remains to be determined.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S7)
Open AccessCardiovascular Health and Cognitive Function in Early Midlife: A Cross‐Sectional Analysis of the 1970 British Cohort Study
Background: Poor cardiovascular health in midlife increases risk of dementia in later years. At least some of this risk may stem from early decrements in cognitive ability in those with poor cardiovascular health that are already evident by midlife. Whether such associations are causal, however, or develop in tandem due to shared factors encountered earlier in life, remains unclear.Method: A modified version of the American Heart Association Life’s Essential 8 (LE8) cardiovascular health score was constructed in 8,226 participants (age 47 years) recruited to the 1970 British Cohort Study. Four biological (BMI, blood pressure, glucose, total cholesterol) and four behavioral (diet, physical activity, smoking, sleep) metrics were each categorized as 0 (poor), 1 (intermediate), or 2 (ideal) and summed to create the LE8 score. A cognitive test battery assessing immediate and delayed memory recall, executive function, processing speed, and overall cognitive function were chosen as outcomes. Multiple linear regressions employing multiple imputation and adjusting for a range of early (childhood socioeconomic status, household overcrowding, childhood IQ, and highest education level) and mid‐life (current socioeconomic status and malaise) factors were used to conduct analyses whilst accounting for missing data.Result: Overall cognitive function in those classed as having ideal (LE8>13 points) cardiovascular health was 0.15 (0.04–0.27) z‐scores higher than those with intermediate (LE8 9‐13 points) and 0.42 (0.30–0.55) z‐scores higher than those with poor (<9 points) cardiovascular health. In age‐ and sex‐adjusted analyses, each 1‐point increase in LE8 was associated with a 0.02–0.06 z‐score higher cognitive function in all domains (p<0.001 for all). These associations became null for executive function and processing speed once accounting for early‐life factors, however, and were substantially attenuated for both memory domains. Further adjustment for midlife factors had little further impact on estimates. Follow‐up analyses suggested stronger relationships between midlife cardiovascular health behaviors and cognitive ability than biological factors.Conclusion: Much of the observed relationship between cardiovascular health and cognitive ability in early midlife is likely explained by other shared early‐life factors. While a modest association still persists after accounting for these factors, the directionality of this relationship remains to be determined.